Skip to content

Evaluating a risk prediction tool and other factors to predict complication after cancer related digestive surgeries

Evaluation of the E-PASS Risk Prediction Model and Additional Perioperative Risk Factors for Postoperative Morbidity in Major Elective Oncologic Hepatobiliary Surgery A Retrospective Observational Cohort Study - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110704
Enrollment
400
Registered
2026-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

ACTREC, TMC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing major elective oncologic upper GI/ hepatobiliary surgery, including hepatectomy, hepatic resection with bile duct resection, hilar cholangiocarcinoma surgery, gastrectomy, cholecystectomy, pancreaticoduodenectomy or major pancreatic resections, RP mass excisions. 2.Elective surgery with curative intent

Exclusion criteria

Exclusion criteria: 1.Emergency surgeries 2.Incomplete perioperative data required for E-PASS calculation

Design outcomes

Primary

MeasureTime frame
To evaluate the predictive accuracy of the E-PASS Comprehensive Risk Score (CRS) for postoperative morbidity graded by the Clavien Dindo classification. Timepoint: 30 days

Secondary

MeasureTime frame
To evaluate the association of additional perioperative variables (6-minute walk test, serum albumin, BMI, history of cerebrovascular accident, and cancer stage) with postoperative morbidity.Timepoint: Upto 30 days;To develop a refined morbidity prediction model incorporating E-PASS components and additional independent predictorsTimepoint: Upto 30 days;To compare the discriminative performance of the refined model with the original E-PASS scoreTimepoint: Upto 30 days;To evaluate correlation between E-PASS CRS and postoperative morbidity survey (POMS) scores within 30 daysTimepoint: Upto 30 days;To assess the ability of E-PASS CRS to predict major postoperative complications (Clavien Dindo greater than equal to Grade III) within 30 days and comparative ability between different hepatobiliary surgeries.Timepoint: Upto 30 days

Countries

India

Contacts

Public ContactDr Sarika J Chandran

Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)

divyabhagwat30@gmail.com7208460727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026